Last reviewed · How we verify
benzodiazepines
At a glance
| Generic name | benzodiazepines |
|---|---|
| Also known as | midazolam, lorazepam, chlordiazepoxide |
| Sponsor | Medical University of Warsaw |
| Modality | Small molecule |
| Therapeutic area | Other |
| Phase | FDA-approved |
Approved indications
Common side effects
Key clinical trials
- SMILE Trial - Imaging Sub-Study
- Comparison of Two Intravenous Drug Combinations for Ambulatory Oral & Maxillofacial Surgery (PHASE1)
- A Study of LY4268989 (MORF-057) in Healthy Participants (PHASE1)
- Management of Catatonic Features in Adolescents With Profound Autism (NA)
- A Study to Learn About the Study Medicine Called PF-07799933 in People With Advanced Solid Tumors With BRAF Alterations. (PHASE1)
- Evaluation of VX-828 in Healthy Participants and in Participants With Cystic Fibrosis (PHASE1)
- A Clinical Trial in Healthy Participants to Learn How Itraconazole Affects MK-2828 Levels and How MK-2828 Affects Midazolam Levels (MK-2828-007) (PHASE1)
- Machine-Learning Prediction and Reducing Overdoses With EHR Nudges (NA)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- benzodiazepines CI brief — competitive landscape report
- benzodiazepines updates RSS · CI watch RSS
- Medical University of Warsaw portfolio CI